Menu
03/02/2005
Warning issued over hyperactivity treatment
The Medicines and Healthcare products Regulatory Agency (MHRA) have issued a warning, after a drug prescribed for children was linked to possible liver damage.
Strattera – also known as atomoxetine –was launched in the UK last summer and has been used to treat attention deficit hperactivity disorder (ADHD) in children.
The MHRA has now uncovered evidence which suggests that , in extremely rare cases, the drug may be associated with liver reactions.
Over two million people have treated with the drug in the US and around 10,000 in the UK. The risk of devloping a serious liver reaction while using Strattera has been estimated at around one in 50,000.
Professor Gordon Duff, Chairman of the Committee on Safety of Medicines, said that Strattera had been an important drug in the treatment of ADHD in children and urged doctors and parents to take a "balanced approach" to the new evidence. He said: "Parents should not be dissuaded from having their children treated with this medicine, but it is right that they should be aware of possible, but rare, side effects."
Professor Duff said that new advice regarding Strattera would be issued to doctors, along with a question-and-answer sheet for parents and patients, which would help them to be alert to any signs of liver problems in children taking the drug. He said: "We have advised doctors that if they suspect that liver problems are occuring, treatment should be stopped and an alternative treatment initiated."
The Committee on Safety of Medicines as advised that further work should be undertaken to establish what may be causing these side effects in a small minority of patients, in order to help identify those who would be most likely to be affected.
(KMcA/SP)
Strattera – also known as atomoxetine –was launched in the UK last summer and has been used to treat attention deficit hperactivity disorder (ADHD) in children.
The MHRA has now uncovered evidence which suggests that , in extremely rare cases, the drug may be associated with liver reactions.
Over two million people have treated with the drug in the US and around 10,000 in the UK. The risk of devloping a serious liver reaction while using Strattera has been estimated at around one in 50,000.
Professor Gordon Duff, Chairman of the Committee on Safety of Medicines, said that Strattera had been an important drug in the treatment of ADHD in children and urged doctors and parents to take a "balanced approach" to the new evidence. He said: "Parents should not be dissuaded from having their children treated with this medicine, but it is right that they should be aware of possible, but rare, side effects."
Professor Duff said that new advice regarding Strattera would be issued to doctors, along with a question-and-answer sheet for parents and patients, which would help them to be alert to any signs of liver problems in children taking the drug. He said: "We have advised doctors that if they suspect that liver problems are occuring, treatment should be stopped and an alternative treatment initiated."
The Committee on Safety of Medicines as advised that further work should be undertaken to establish what may be causing these side effects in a small minority of patients, in order to help identify those who would be most likely to be affected.
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
21 June 2006
Government announces funding for drug treatment services
Drug treatment services across the country will receive an extra £95.2 million this year, under new plans announced by the government. The Department of Health, supported by £22 million of funding from the Home Office, will provide Drug Action Teams with £394.6 million - an increase of over 30% from last year.
Government announces funding for drug treatment services
Drug treatment services across the country will receive an extra £95.2 million this year, under new plans announced by the government. The Department of Health, supported by £22 million of funding from the Home Office, will provide Drug Action Teams with £394.6 million - an increase of over 30% from last year.
09 July 2003
Rise in crack users sent for treatment
More crack users are being targeted in custody and referred to drug treatment services, a new report published by the Home Office claims. The 'Arrest Referral' report shows that between October 2001 and September 2002, 12,014 crack users were interviewed, and of those 8,656 were referred to specialist drug treatment services - 18.
Rise in crack users sent for treatment
More crack users are being targeted in custody and referred to drug treatment services, a new report published by the Home Office claims. The 'Arrest Referral' report shows that between October 2001 and September 2002, 12,014 crack users were interviewed, and of those 8,656 were referred to specialist drug treatment services - 18.
22 May 2008
Alcohol Related Admissions Increasing, Report Finds
A report released today reveals that alcohol related admissions have increased dramatically since 1995. The NHS report shows that alcohol was the main or secondary cause of 207,800 NHS admissions between 2006 and 2007 compared to just 93,500 between 1995 and 1996.
Alcohol Related Admissions Increasing, Report Finds
A report released today reveals that alcohol related admissions have increased dramatically since 1995. The NHS report shows that alcohol was the main or secondary cause of 207,800 NHS admissions between 2006 and 2007 compared to just 93,500 between 1995 and 1996.
30 January 2009
Pandemic Flu Drug Stockpiles Set To Double
The UK today awarded contracts to double emergency supplies of flu drugs to treat everyone who is predicted to fall ill in a pandemic, making the UK one of the most prepared countries in the world. The agreements with Roche and GlaxoSmithKline will double antiviral stockpiles, which are expected to be in place by April 2009.
Pandemic Flu Drug Stockpiles Set To Double
The UK today awarded contracts to double emergency supplies of flu drugs to treat everyone who is predicted to fall ill in a pandemic, making the UK one of the most prepared countries in the world. The agreements with Roche and GlaxoSmithKline will double antiviral stockpiles, which are expected to be in place by April 2009.
07 January 2005
Reid hails mobile treatment centres as success
According to a report published today more than 120,000 patients have been treated since the start of the government's pioneering Treatment Centre programme, in some cases up to eight times faster than traditional NHS providers.
Reid hails mobile treatment centres as success
According to a report published today more than 120,000 patients have been treated since the start of the government's pioneering Treatment Centre programme, in some cases up to eight times faster than traditional NHS providers.
-
Northern Ireland WeatherToday:It will be cloudy again throughout the day. Mainly dry in the morning, but patchy drizzle in places, becoming more widespread and persistent in the afternoon. Freshening southwesterly winds. Maximum temperature 12 °C.Tonight:Cloudy with a spell of heavy rain pushing south through late evening and the early hours, followed by some clear spells. Minimum temperature 6 °C.
